Mechanisms of resistance to oxidative stress in Alzheimer's disease

BioFactors

Volumn 8, Issue 1-2, 1998, Pages 45-50

  Sagara, Yutaka ^a   Tan, Shirlee ^a   Maher, Pamela ^b   Schubert, David ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CATALASE; GLUTATHIONE PEROXIDASE;

AEROBIC METABOLISM; ALZHEIMER DISEASE; CONFERENCE PAPER; CYTOTOXICITY; ENZYME INACTIVATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0031873849     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520080109     Document Type: Conference Paper

References (35)

1. A.J. Anderson, J.H. Su and C.W. Cotman, DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay, J. Neurosci. 16 (1996), 1710-1719.
2. L. Balazs and M. Leon, Evidence of an oxidative challenge in the Alzheimer's brain, Neurochem. Res. 19 (1994), 1131-1137.
3. C. Behl, J. Davis, G.M. Cole and D. Schubert, Vitamin E protects nerve cells from amyloid β-protein toxicity, Biochem. Biophys. Res. Comm. 186 (1992), 944-950.
4. C. Behl, J.B. Davis, F.G. Klier and D. Schubert, Amyloid β-peptide induces necrosis rather than apoptosis, Brain Res. 645 (1994), 253-264.
5. C. Behl, J.B. Davis, R. Lesley and D. Schubert, Hydrogen peroxide mediates amyloid β-protein toxicity, Cell 77 (1994), 817-827.
6. X.-D. Cai, T. Golde and S. Younkin, Release of excess amyloid β-protein from a mutant amyloid beta-protein precursor, Science 259 (1993), 514-516.
7. M.-C. Chartier-Harlin, F. Crawford, H. Houlden, A. Warren, D. Hughes, L. Fidani, A. Goate, M. Rossor, P. Roques, J. Hardy and M. Mullan, Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene, Nature 353 (1991), 844-846.
8. M. Citron, T. Oltersorf, C. Haass, L. McConlogue, A.Y. Hung, P. Seubert, C. Vigo-Pelfrey, I. Lieberburg and D.J. Selkoe, Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production, Nature 360 (1992), 672-674.
9. J.R. Connor, S.L. Menzies, S.M. St.-Martin and E.J. Mufson, A histochemical study of iron, transferrin and ferritin in Alzheimer's diseased brains, J. Neurosci. Res. 31 (1992), 75-83.
10. K. Duff, C. Eckman, C. Zehr, X. Yu, C.-M. Prada, J. Perez-Tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M.N. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy and S. Younkin, Increased amyloid-β 42 (43) in brains of mice expressing mutant presenilin 1, Nature 383 (1996), 710-713.
11. P. Eikelenboom, S.-S. Zhan, W.A. van Gool and D. Allsop, Inflammatory mechanisms in Alzheimer's disease, TIPS 15 (1994), 447-450.
12. A.L. Friedlich and L.L. Butcher, Involvement of free oxygen radicals in beta-amyloidosis: An hypothesis, Neurobiol. Ageing 15 (1994), 443-455.
13. A. Goate, M.-C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, L. James, R. Mant, P. Newton, K. Rooke, P. Roques, C. Talbot, M. Pericak-Vance, A. Roses, R. Williamson, M. Rossor, M. Owen and J. Hardy, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991), 704-706.
14. P.R. Hof, E.A. Nimchinsky, M.R. Celio, C. Bouras and J.H. Morrison, Calretinin-immunorreactive neocortical interneurons are unaffected in Alzheimer's disease, Neurosci. Lett. 152 (1993), 145-149.
15. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang and G. Cole, Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice, Science 274 (1996), 99-102.
16. G.R. Jackson, D. Sampath, K. Werrbach-Perez and R. Perez-Polo, Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma subclone, Brain Res. 634 (1994), 69-76.
17. M.A. Lovell, W.D. Ehmann, S.M. Butler and W.R. Markesbury, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease, Neurology 45 (1995), 1594-1601.
18. L. Lyras, N.J. Cairns, A. Jenner, P. Jenner and B. Halliwell, An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease, J. Neurochem. 68 (1997), 2061-2069.
19. P.L. McGeer and E.G. McGeer, The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Res. Rev. 21 (1995), 195-218.
20. P. Mecocci, U. MacGarvey and M. Geal, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Ann. Neurol. 36 (1994), 747-751.
21. J.A. Mortimer, L.R. French, J.T. Hutton and L.M. Schuman, Head injury as a risk factor for Alzheimer's disease, Neurology 35 (1985), 264-267.
22. J. Murrell, M. Farlow, B. Ghetti and M.D. Benson, A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease, Science 254 (1991), 97-99.
23. M.A. Pappolla, R.A. Omar, K.S. Kim and N.K. Robakis, Immunohistochemical evidence of antioxidant stress in Alzheimer's disease, Am. J. Pathol. 140 (1992), 621-628.
24. C.J. Pike, D. Burdick, A.J. Walencewicz, C.G. Glabe and C.W. Cotman, Neuro-degeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci. 13 (1993), 1676-1687.
25. Y. Sagara, R. Dargusch, D. Schubert and C. Behl, Increased antioxidant enzyme activity Aβ-resistant cells, J. Neurosci. 16 (1996), 497-505.
26. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease, New Engl. J. Med. 336 (1997), 1216-1222.
27. D. Schubert and M. Chevion, The role of iron in beta amyloid toxicity, Biochem. Biophys. Res. Comm. 216 (1995), 702-707.
28. M.S. Shearman, C.I. Ragan and L.L. Iversen, Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death, Proc. Natl. Acad. Sci. USA 91 (1994), 1470-1474.
29. M.A. Smith, P.L.R. Harris, L.M. Sayre, J.S. Beckman and G. Perry, Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci. 17 (1997), 2653-2657.
30. M.A. Smith, G. Perry, P.L. Richey, L.M. Sayre, V.E. Anderson, M.F. Beal and N. Kowall, Oxidative damage in Alzheimer's, Nature 382 (1996), 120-121.
31. K.V. Subarao, S. Richardson and L.C. Ang, Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro, J. Neurochem. 55 (1990), 342-345.
32. S. Tan, P. Maher and D. Schubert, The role of protein phosphorylation in beta amyloid toxicity, Brain Res. 765 (1997), 159-163.
33. T. Tomita, K. Maruyama, T.C. Saido, H. Kume, K. Shinozaki, S. Tokuhiro, A. Capell, J. Walter, J. Grunberg, C. Haass, T. Iwatsubo and K. Obata, The presenilin 2 mutation (N141I) linked to familial Alzheimer's disease (Volga German families) increases the secretion of amyloid β-protein ending at the 42nd (or 43rd) residue, Proc. Natl. Acad. Sci. USA 94 (1997), 2025-2030.
34. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern and A.M. Schmidt, RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease, Nature 382 (1996), 685-719.
35. B.A. Yankner, L.K. Duffy and D.A. Kirschner, Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides, Science 25 (1990), 279-282.